Rocket, Labs

Rocket Lab's Two-Front Battle: Record Pentagon Haul Versus the Neutron Clock

Published on 08/15/2026 at 13:41 | Redaktion boerse-global.de

Rocket Lab posts record revenue and backlog, but Q2 loss and weak guidance keep investors cautious despite $943M in defense deals.

Rocket Lab's Record Contracts Fail to Lift Stock as Losses Mount
Rocket Lab's Two-Front Battle: Record Pentagon Haul Versus the Neutron Clock Illustration mit AI erstellt übermittelt durch boerse-global.de

There is a peculiar disconnect playing out at Rocket Lab right now. The company is signing contracts at a pace that would make most defense contractors envious, its revenue pipeline is bursting at the seams, and yet the stock market is responding with something closer to a shrug than a celebration. The reason isn't hard to find: every record the company sets only sharpens the focus on the one milestone it hasn't yet delivered.

The Pentagon's New Favorite Supplier

The numbers coming out of Washington are staggering. The US Space Force has awarded Rocket Lab a $397 million contract for "flatellite" satellites designed to track airborne threats in real time under the SB-AMTI program — the company's largest national defense award of the year. That single deal sits atop a pile of additional government work: $190 million for 20 HASTE test flights, $90 million for two geostationary satellites, and $266 million for up to 18 missile-defense launches. All told, Rocket Lab's US government contract haul for 2026 comes to roughly $943 million.

CEO Peter Beck describes what the company is building as a "resilient space sensing layer," and the strategy is becoming clearer by the quarter. Washington is fragmenting its space-defense procurement into smaller, specialized packages spread across multiple vendors rather than concentrated with a single prime contractor. Rocket Lab is positioning itself squarely in that sweet spot — not just as a launch provider but as a vertically integrated systems house that designs satellites, builds them, and launches them on its own rockets. The Space Force also tapped the company for a $12 million slice of a Space Data Network contract alongside Amazon, Lockheed Martin, Northrop Grumman, and York Space Systems — a modest sum but a telling sign of where Rocket Lab now sits in the defense ecosystem.

Record Results, Muted Reaction

The second quarter of 2026 delivered everything a growth investor could ask for on paper. Revenue hit $234.07 million, up 62 percent year over year. The backlog swelled to $2.36 billion, more than doubling from a year earlier. New orders booked during the quarter exceeded $1 billion, including fresh launch contracts worth $437 million on top of the Space Force award.

Space Systems, the division that builds satellites and components rather than rockets, contributed $189.5 million — roughly 81 percent of total revenue. That mix shift is significant: Rocket Lab is no longer primarily a launch company, and Bank of America noted after the results that Space Systems blew past its own $165 million internal forecast. The firm reaffirmed its buy rating with a $115 price target.

Should investors sell immediately? Or is it worth buying Rocket Lab?

Yet the market barely moved on the news, and the stock's lukewarm response tells its own story. The company posted a net loss of $49 million, or minus $0.08 per share, against analyst expectations of just minus $0.03. After-hours trading initially knocked the stock down as much as 8 percent. The guidance for the third quarter didn't help: revenue of $250 million to $265 million came in fine, but the projected gross margin of 29 to 31 percent landed well below the 37.6 percent analysts had penciled in.

The Valuation Tightrope

The paradox of a record-setting company getting sold off makes more sense when you look at the price tag. At roughly 65 times sales, Rocket Lab's valuation leaves almost no room for disappointment. Investors buying at these levels aren't paying for what the company is today; they're paying for a very optimistic version of tomorrow. And that tomorrow hinges almost entirely on one thing: the Neutron rocket.

The first launch of the new vehicle is still officially targeted for late 2026, but Beck himself has acknowledged the window is narrowing, with a slip into early 2027 looking increasingly plausible. The launch pad won't even be delivered until the fourth quarter. Progress is visible — the "Hungry Hippo" fairing recently passed a 275,000-pound strength test and is now receiving thermal protection and avionics — but the timeline is the single biggest risk in the entire investment thesis.

The stakes are concrete. Kepler Communications has booked a dedicated Neutron launch for 2028 to build a laser network with a planned data rate of 100 Gbit/s. The defense contracts also assume Neutron flights. Every delay in the rocket pushes a meaningful chunk of the company's future revenue further out.

A Stock Caught Between Momentum and Caution

The share price behavior reflects this tension. The stock closed at €69.30 on Friday, down a modest 0.3 percent, and sits about 6.6 percent below its 50-day moving average while hovering just above the 200-day average. Over seven trading days it's off 3.2 percent, though it's up 4.2 percent on a monthly basis. The 12-month performance remains impressive at 88 percent, but the recent pattern looks more like consolidation than euphoria — a strange response to a news flow that's been overwhelmingly positive.

Analyst sentiment remains broadly constructive. Seeking Alpha rates the stock a buy with a $209 price target, while Cantor Fitzgerald lifted its target from $96 to $122. The consensus across 17 firms sits at a median price target of $114.24. But the fair-value estimates range wildly, from $16.25 on the low end to $150 on the high end — a spread that captures just how much uncertainty surrounds both Neutron and the company's other big strategic question.

Rocket Lab at a turning point? This analysis reveals what investors need to know now.

The Iridium Question and the Dilution Trade-Off

That other question is the potential acquisition of Iridium, which could bring in recurring annual revenue of roughly $870 million and structurally broaden Rocket Lab's revenue base. But it comes with a cost: a capital raise of $1.06 billion, with potentially another $1.94 billion to follow. Dilution is a genuine concern that investors can't wave away, even if the strategic logic of folding in a satellite operator with steady recurring revenue is compelling.

There's also the GHOST mobile launch system to consider — transportable in standard shipping containers and slated for use at the Pacific Spaceport Complex in Alaska — which adds another layer to the company's military diversification story.

The Waiting Game

What makes Rocket Lab unusual right now is the gap between the operational story and the market's response. The company is riding a wave of defense and space spending that's also lifting SpaceX, Intuitive Machines, and Voyager Technologies. Its backlog is at record levels, its government relationships are deepening, and its revenue is compounding at a remarkable clip.

But none of that will fully register in the share price until Neutron flies. With annualized volatility around 82 percent, this has never been a stock for the faint of heart. The operational story is solid — the question is whether investors have the patience to sit through the volatility while waiting for the one launch that could change everything.

Ad

Rocket Lab Stock: New Analysis - 15 August

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 69952466 |